Transcend Capital Advisors LLC Has $1.49 Million Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Transcend Capital Advisors LLC lifted its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 4.7% during the 4th quarter, Holdings Channel reports. The fund owned 10,975 shares of the financial services provider’s stock after acquiring an additional 497 shares during the quarter. Transcend Capital Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,491,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Column Capital Advisors LLC acquired a new position in shares of iShares Biotechnology ETF in the 3rd quarter worth approximately $49,000. Premier Path Wealth Partners LLC acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter worth approximately $207,000. StrategIQ Financial Group LLC lifted its holdings in iShares Biotechnology ETF by 9.2% during the 4th quarter. StrategIQ Financial Group LLC now owns 5,013 shares of the financial services provider’s stock worth $681,000 after buying an additional 422 shares in the last quarter. Brookstone Capital Management lifted its holdings in iShares Biotechnology ETF by 4.1% during the 4th quarter. Brookstone Capital Management now owns 6,753 shares of the financial services provider’s stock worth $917,000 after buying an additional 269 shares in the last quarter. Finally, Congress Wealth Management LLC DE acquired a new position in iShares Biotechnology ETF during the 3rd quarter worth $265,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Up 0.7 %

NASDAQ:IBB traded up $0.82 during trading hours on Friday, hitting $126.49. 833,050 shares of the stock were exchanged, compared to its average volume of 1,534,186. The company’s 50 day moving average is $134.27 and its two-hundred day moving average is $129.74. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were issued a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a yield of 0.40%. The ex-dividend date was Thursday, March 21st.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.